About Index Trending news
Analyze
Pricing
Ambit Biosciences

Ambit Biosciences

Work at Ambit Biosciences? Add yourself to this profile

Ambit Biosciences

Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.
Edit Profile
More info

Elsewhere

Also headquartered in San Diego

Qualcomm Qualcomm Intuit Intuit GoFundMe GoFundMe Illumina Illumina Software Company Software Company Industry Industry Nervana Nervana Tower Tower Emotient Emotient Medical Marijuana Medical Marijuana

Companies in the same industry

Mast Therapeutics, Inc. Mast Therapeutics, Inc. BioCision BioCision Diomics Diomics Vasopharm Vasopharm Cofactor Genomics Cofactor Genomics Cariloop Cariloop GlassesOff GlassesOff InPulse Medical InPulse Medical Molecular Imaging Molecular Imaging Izun Pharmaceuticals Izun Pharmaceuticals

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 3
Add info
Acquired by
29 Sep 2014
Daiichi Sankyo Co., Ltd.
$410,000,000
Latest funding Show all
Venture capital
$50,000,000
Venture capital (Series D)
$30,000,000
Locations
HQ
San Diego, United States
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Ambit Biosciences makes some noise.